drugset / Trial / NCT04590404
Metabolism Informed Smoking Treatment: The MIST RCT
Phase 3
Completed
606 enrolled
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This phase 3 randomized controlled trial will test Metabolism-Informed Smoking Treatment (MIST), a precision approach to smoking treatment that biologically tailors medication selection to nicotine metabolism.
Timeline
- Start
- 2020-11-17
- Primary completion
- 2024-05-20
- Completion
- 2024-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | — | — |
Indications
No indication recorded.